ELVN
Enliven Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+0.95%
vs ±11.2% implied · ×0.08
shaded = implied · ▲▼ = realized
No thesis.
Enliven Therapeutics, Inc.
44.25
−0.83 · −1.83%
post 44.25 0.00%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $508.8M | 12.45% | +46.80% | |
| 2 | Orbimed AdvisorsOrbimed | $343.9M | 8.42% | −14.86% | |
| 3 | Polar Capital HoldingsPolar Capital | $326.4M | 7.99% | +26.94% | |
| 4 | BlackRockBlackRockindex-like | $221.3M | 5.42% | +18.32% | |
| 5 | Vestal Point CapitalVestal Point Capital | $203.0M | 4.97% | +23.08% | |
| 6 | Commodore CapitalCommodore Capital | $166.2M | 4.07% | 0.00% | |
| 7 | T. Rowe Price AssociatesT. Rowe Price | $147.4M | 3.61% | +2870.84% | |
| 8 | Vanguard Capital ManagementVanguardindex-like | $130.4M | 3.19% | new | |
| 9 | Citadel AdvisorsCitadel | $108.7M | 2.66% | +14.40% | |
| 10 | Fairmount Funds ManagementFairmount Funds | $94.2M | 2.31% | 0.00% | |
| 11 | SirenSiren | $90.1M | 2.20% | +137.78% | |
| 12 | Bellevue GroupBellevue | $75.6M | 1.85% | −35.80% | |
| 13 | Geode Capital ManagementGeodeindex-like | $71.4M | 1.75% | +31.96% | |
| 14 | First Light Asset ManagementFirst Light | $69.1M | 1.69% | +574.08% | |
| 15 | State StreetState Streetindex-like | $61.6M | 1.51% | +11.23% | |
| 16 | Pictet Asset Management HoldingPictet | $59.0M | 1.44% | +24.98% | |
| 17 | Adage Capital Partners GPAdage Capital Partners GP | $55.0M | 1.35% | new | |
| 18 | NovoNovo | $50.8M | 1.24% | −21.88% | |
| 19 | First Turn ManagementFirst Turn | $48.4M | 1.19% | +52.98% | |
| 20 | Samlyn CapitalSamlyn Capital | $46.3M | 1.13% | new | |
| 21 | Baker Bros. AdvisorsBaker Bros. | $45.9M | 1.12% | 0.00% | |
| 22 | Candriam Luxembourg S.C.A.Candriam Luxembourg S.C.A. | $45.9M | 1.12% | +52.45% | |
| 23 | AlliancebernsteinAlliancebernstein | $45.5M | 1.11% | +16.10% | |
| 24 | Tri Locum PartnersTri Locum Partners | $44.0M | 1.08% | new | |
| 25 | Dimensional Fund AdvisorsDimensional | $34.1M | 0.83% | −1.51% |
212 managers report $4.1B of Enliven Therapeutics on form 13F for the quarter ended Jun 30 '26. 32 of them hold 80% of it; FMR is largest at 12.45%.
Expected move
Inputs8Q avg ±3.0%·×2.02·rich
straddle ±10.7%
spot 44.25exp Nov 20ATM strike 45ATM straddle 5.57IV 65%